Corteva, Inc. $CTVA Position Decreased by Eurizon Capital SGR S.p.A.

Eurizon Capital SGR S.p.A. lowered its position in Corteva, Inc. (NYSE:CTVA) by 22.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 410,143 shares of the company’s stock after selling 116,891 shares during the period. Eurizon Capital SGR S.p.A. owned approximately 0.06% of Corteva worth $31,848,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Parkside Financial Bank & Trust lifted its position in Corteva by 3.2% during the second quarter. Parkside Financial Bank & Trust now owns 3,729 shares of the company’s stock valued at $316,000 after acquiring an additional 116 shares during the last quarter. HB Wealth Management LLC grew its holdings in Corteva by 0.5% in the second quarter. HB Wealth Management LLC now owns 23,822 shares of the company’s stock worth $2,018,000 after purchasing an additional 128 shares during the last quarter. Wilkerson Advisory Group LLC grew its holdings in Corteva by 6.7% in the first quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company’s stock worth $177,000 after purchasing an additional 133 shares during the last quarter. Aviance Capital Partners LLC increased its position in shares of Corteva by 1.3% during the first quarter. Aviance Capital Partners LLC now owns 11,008 shares of the company’s stock worth $922,000 after purchasing an additional 137 shares in the last quarter. Finally, Pinnacle Wealth Management Advisory Group LLC increased its position in shares of Corteva by 3.2% during the second quarter. Pinnacle Wealth Management Advisory Group LLC now owns 4,762 shares of the company’s stock worth $403,000 after purchasing an additional 147 shares in the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Latest Corteva News

These are some of the CTVA news items that stood out recently:

• Neutral Sentiment: Several analysts lowered price targets following the outlook reset. Citigroup and UBS kept neutral ratings, while JPMorgan maintained overweight and RBC kept outperform ratings, signaling some analysts still see potential upside from recent levels. Read More. · Read More. · Read More. · Read More.
• Negative Sentiment: The earnings miss and lowered full-year outlook are the key near-term headwinds, with Brazil weakness and competitive pricing hurting results. Reuters report on Brazil weakness and forecast cut
• Negative Sentiment: Law firms announced investigations into potential securities-law violations related to company disclosures. These are allegations under investigation, not findings of wrongdoing, but may add uncertainty for investors. Law firm investigation announcement

Corteva Price Performance

Shares of CTVA opened at $9.41 on Friday. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.56 and a quick ratio of 1.10. The company’s fifty day moving average price is $37.22 and its 200-day moving average price is $69.57. Corteva, Inc. has a 1-year low of $9.01 and a 1-year high of $90.97. The firm has a market capitalization of $6.28 billion, a PE ratio of 4.96, a price-to-earnings-growth ratio of 1.72 and a beta of 0.58.

Corteva Cuts Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Tuesday, December 1st will be given a dividend of $0.05 per share. The ex-dividend date of this dividend is Tuesday, December 1st. This represents a $0.20 dividend on an annualized basis and a yield of 2.1%. This is a decrease from Corteva’s previous quarterly dividend of $0.18. Corteva’s payout ratio is presently 47.68%.

Analysts Set New Price Targets

Several analysts have recently commented on CTVA shares. Deutsche Bank reissued a “buy” rating and issued a $101.00 price objective on shares of Corteva in a research report on Monday, August 3rd. Weiss Ratings lowered Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 3rd. JPMorgan Chase & Co. reduced their target price on Corteva from $19.00 to $16.00 and set an “overweight” rating on the stock in a research report on Friday. UBS Group decreased their price target on Corteva from $15.00 to $10.00 and set a “neutral” rating for the company in a research note on Friday. Finally, Royal Bank Of Canada lowered their price target on Corteva from $17.00 to $11.00 and set an “outperform” rating for the company in a report on Friday. Fifteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $52.60.

About Corteva

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.